We found 229 records for "Financial"

Articles

Should pharma be envious of Apple?

9th February 2015

 Should pharma be envious of Apple?Articles

Apple has just recorded the biggest profits in corporate history – how did it achieve this, and does pharma measure up in terms of innovation and marketing?Apple recently announced a...

Read more

Wales’ life science hub: six months on

29th January 2015

 Wales’ life science hub: six months onArticles

pharmaphorum speaks to Dr Ian Barwick, chief operating officer of the Life Sciences Hub Wales, about where the group stands six months from launch and how its partnership with a...

Read more

20 People who shaped healthcare in 2014 (Part 4)

2nd January 2015

 20 People who shaped healthcare in 2014 (Part 4)Articles

In the final instalment of our review of 2014, Andrew McConaghie looks at how patient advocates in rare diseases and 'activist investors' have shaped healthcare – and will continue to...

Read more

20 people who shaped healthcare in 2014 (part 2)

29th December 2014

 20 people who shaped healthcare in 2014 (part 2)Articles

In the second part of our review of 2014, Andrew McConaghie looks at five more individuals who played a prominent role in shaping healthcare this year - and all of...

Read more

News

Bayer sets big targets for 2015

27th February 2015

 Bayer sets big targets for 2015News

Bayer will need a stellar performance from its growth products this year, as it is predicting a €4 billion increase in group sales to €46 billion in 2015.The company is...

Read more

Is Pharmacyclics weighing up a sale?

26th February 2015

 Is Pharmacyclics weighing up a sale? News

Shares in Pharmacyclics leapt yesterday on speculation that the company is considering a sale, with Johnson & Johnson (J&J) considered the most likely buyer.Pharmacyclics is riding high at the moment,...

Read more

Merck takes stake in NGM amid flurry of pharma deals

24th February 2015

 Merck takes stake in NGM amid flurry of pharma dealsNews

Merck & Co has taken an equity stake in NGM Biopharmaceuticals as part of a wide-ranging alliance to develop drugs to treat diabetes, obesity and other metabolic diseases.The US pharma...

Read more

Valeant agrees $10 billion takeover of Salix

23rd February 2015

 Valeant agrees $10 billion takeover of SalixNews

Last year's rumour of a Salix acquisition by Valeant proved well-founded, with the two companies announcing a $10 billion deal over the weekend.Canada's Valeant is paying $158 per share for...

Read more

White Papers

"The future ain’t what it used to be"

25th November 2014

 "The future ain’t what it used to be"White Papers

Preparation is key to creating and maintaining a strong drugs pipeline. However, the statistics demonstrate that successful product commercialisation strategies are not always implemented. Products are developed for which there...

Read more

Healthcare Innovation: the big ideas shaping the future of pharma

17th November 2014

 Healthcare Innovation: the big ideas shaping the future of pharmaWhite Papers

The transformation taking place in healthcare is challenging for everyone and adaptability is key for the pharma industry's continued success.Long production cycles, concentration on specialist drugs with high price tags,...

Read more

Redefining Market Access - Effective Value Engagement

3rd December 2013

 Redefining Market Access - Effective Value EngagementWhite Papers

Phenestra's latest white paper highlights the challenges in market access and reimbursement for every company involved in developing new and innovative drugs.Today, every pharmaceutical company has the patient at the...

Read more

Audio & Video

Live webinar/debate - Feb 4th - COPD, connecting real world needs to patient centric solutions

    COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and is recognised as the ‘third-leading’ cause of death in most countries. Adherence rates...

Read more

On demand webinar: The Price is Right? - Delivering UK access for niche patient populations

  With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the ramifications for high priced/innovative treatments delivering beneficial outcomes...

Read more

Events

ACOs and Industry: A Collaboration for Value

26th March 2015 - 27th March 2015

ACOs and Industry: A Collaboration for Value

Exclusive Access to ACO Execs – Learn about ACOs and healthcare changes impacting your business and your customers DIRECTLY from leaders of major health systems. This conference is vastly different...

Read more

Learning from high-performing health care organisations

21st April 2015

Learning from high-performing health care organisations

This event examines how sustainable improvement in the NHS will come from strong commitment and learning from high-performers in England and abroad. ...

Read more

Risk Forum

27th April 2015 - 28th April 2015

Risk Forum

With ACO development heating up, the Exchanges rolling out, and ICD-10 implementation right around the corner, there is no better time than to get together and discuss best practices for...

Read more

The Annual Population Health Management Forum

27th April 2015 - 28th April 2015

The Annual Population Health Management Forum

Key topics: Identifying and stratifying risk Promoting health and wellness Implementing targeted programs based on identified risk Integrating...

Read more

Press Releases

New Schoonveld book is now available!

10th December 2014

New Schoonveld book is now available!

It's here!   The eagerly awaited new editon of THE PRICE OF GLOBAL HEALTH  is now available.   Written by global drug pricing expert Ed Schoonveld, The Price of Global Health (second edition) is...

Read more

Gower's latest Pharmaceutical and Healthcare Industry Catalogue

18th September 2014

Gower's latest Pharmaceutical and Healthcare Industry Catalogue

The latest Gower Pharmaceutical and Healthcare Industry Books Catalogue is now available online! Expanding on the Pharma and Health content this year, we have added details of books from our Governance & Leadership...

Read more

Aqurance launches Market Research & Predictive Analytics Services

3rd July 2014

Aqurance launches Market Research & Predictive Analytics Services

Athens, GR, July 02, 2014: Aqurance, a dynamic startup that specializes inLife Sciences consulting and technology implementation services, has recently announced the launch of a new business department, the Market...

Read more